SVCM
ABVX

Saturn V Capital Management’s Abivax ABVX Stock Holding History

Saturn V Capital Management’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$69.1M Sell
518,865
-23,831
-4% -$2.7M 9.91% 3
2026
Q1 		$60.4M Sell
542,696
-106,483
-16% -$12.6M 10.94% 3
2025
Q4 		$87.5M Sell
649,179
-152,045
-19% -$16.6M 16.07% 1
2025
Q3 		$68M Buy
801,224
+178,745
+29% +$11M 14.92% 1
2025
Q2 		$4.76M Buy
622,479
+69,553
+13% +$453K 1.93% 18
2025
Q1 		$3.46M Sell
552,926
-100,145
-15% -$678K 1.74% 16
2024
Q4 		$4.78M Buy
653,071
+5,052
+0.8% +$46.5K 1.87% 15
2024
Q3 		$7.47M Buy
648,019
+20,259
+3% +$243K 2.67% 14
2024
Q2 		$8.3M Buy
627,760
+4,790
+0.8% +$68.5K 3.14% 14
2024
Q1 		$8.91M Buy
+622,970
New +$8.03M 3.57% 14

Other funds holding ABVX

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $3.35B AUM 55.08% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Saturn V Capital Management's ABVX Position: Q2 2026 in Review

Saturn V Capital Management reduced its Abivax (ABVX) stake by 4.4% in Q2 2026, selling an estimated $2.7M and leaving 518,865 shares worth $69.1M. The position accounts for 9.91% of the portfolio, ranked #3.

Saturn V Capital Management first reported a position in ABVX in Q1 2024 and has held it in 10 quarters since. The position peaked at $87.5M in Q4 2025. 302 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • Saturn V Capital Management held 518,865 shares of Abivax worth $69.1M as of Q2 2026.
  • Saturn V Capital Management sold 23,831 Abivax shares in Q2 2026, an estimated $2.7M.
  • Abivax made up 9.91% of Saturn V Capital Management's portfolio in Q2 2026, its #3 holding.
  • Saturn V Capital Management first reported a position in Abivax in Q1 2024 and has held it in 10 quarters since.
  • Saturn V Capital Management's Abivax position peaked at $87.5M in Q4 2025.
  • 302 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on Saturn V Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.